Advances and challenges in using nirmatrelvir and its derivatives against SARS-CoV-2 infection
Author:
Publisher
Elsevier BV
Subject
Analytical Chemistry,Electrochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Pharmacy
Reference66 articles.
1. Supervised Molecular Dynamics (SuMD) Insights into the mechanism of action of SARS-CoV-2 main protease inhibitor PF-07321332;Pavan;J. Enzyme Inhib. Med. Chem.,2021
2. Health anxiety, health perception, and Healthy Lifestyle behavior among psychiatric patients during the COVID-19 pandemic;Korkmaz;Prim. Care Companion. CNS Disord.,2022
3. An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19;Owen;Science,2021
4. COVID-19 vaccination among the arab bedouin population: Lessons Learned from a minority population;Abu-Freha;Int. J. Public Health,2022
5. First-generation oral antivirals against SARS-CoV-2;Sendi;Clin. Microbiol. Infect.,2022
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions;European Journal of Medicinal Chemistry;2024-11
2. Viral myocarditis: From molecular mechanisms to therapeutic prospects;European Journal of Pharmacology;2024-11
3. A comprehensive review of small molecule drugs approved by the FDA in 2023: Advances and prospects;European Journal of Medicinal Chemistry;2024-10
4. Hazards of antiviral contamination in water: Dissemination, fate, risk and their impact on fish;Journal of Hazardous Materials;2024-09
5. Density functional theory and enzyme studies support interactions between angiotensin receptor blockers and angiotensin converting enzyme-2: Relevance to coronavirus 2019;Bioorganic Chemistry;2024-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3